Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)Jonathan I. Silverberg, Andreas Wollenberg, Ayman Grada et al.|Dermatology and Therapy|2025Cited by 4
Questionnaire survey among ophthalmic allergists on dupilumab-associated ocular surface disease in JapanJun Shoji, Nobuyuki Ebihara, Y. Asada et al.|Allergology International|2024Cited by 2
How do atopic dermatitis trialists perceive the Harmonising Outcomes Measurement in Eczema (HOME) core outcome set? A survey study from the HOME initiativeYuval Gilad, Yael A. Leshem, Eric L. Simpson et al.|Clinical and Experimental Dermatology|2025Cited by 2
International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectivesManuel P. Pereira, Torsten Zuberbier, Katarina Stevanovic et al.|JDDG Journal der Deutschen Dermatologischen Gesellschaft|2025Cited by 1
Internationale Umfrage zur Behandlungspraktiken bei atopischer Dermatitis bei schwangeren und stillenden Frauen: Perspektiven von ÄrztenManuel P. Pereira, Torsten Zuberbier, Katarina Stevanovic et al.|JDDG Journal der Deutschen Dermatologischen Gesellschaft|2025Cited by 0